Lineage Cell Therapeutics Inc logo

Lineage Cell Therapeutics Inc

NEW
STU:BT3 (USA)  
€ 0.96 +0.046 (+5.03%) Jul 30
At Loss
P/B:
5.16
Market Cap:
€ 241.33M ($ 277.84M)
Enterprise V:
€ 195.83M ($ 225.46M)
Volume:
4.00
Avg Vol (2M):
0
Trade In:

My Checklist

Inactive
Item Name
Rating
Action

Fair Value Votes

Date Voted
Fair Value
Price on Date Voted
% Change Since Voted
% Change Relative to SP500
10/Page
Total 0

My Votes

My Vote : €